387 related articles for article (PubMed ID: 37629143)
21. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021.
Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661
[TBL] [Abstract][Full Text] [Related]
22. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Carazo S; Skowronski DM; Brisson M; Barkati S; Sauvageau C; Brousseau N; Gilca R; Fafard J; Talbot D; Ouakki M; Gilca V; Carignan A; Deceuninck G; De Wals P; De Serres G
Lancet Infect Dis; 2023 Jan; 23(1):45-55. PubMed ID: 36152671
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data.
Bello-Chavolla OY; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Fernández-Chirino L; Basile-Alvarez MR; Sánchez-Castro P; Núñez-Luna A; Antonio-Villa NE
Lancet Reg Health Am; 2024 Feb; 30():100688. PubMed ID: 38327277
[TBL] [Abstract][Full Text] [Related]
24. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
[TBL] [Abstract][Full Text] [Related]
25. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis.
Ismail NF; Rahman AE; Kulkarni D; Zhu F; Wang X; Del Carmen Morales G; Srivastava A; Allen KE; Spinardi J; Kyaw MH; Nair H
J Glob Health; 2023 Nov; 13():06051. PubMed ID: 37994839
[TBL] [Abstract][Full Text] [Related]
26. Epidemiologic Features of Recovery From SARS-CoV-2 Infection.
Oelsner EC; Sun Y; Balte PP; Allen NB; Andrews H; Carson A; Cole SA; Coresh J; Couper D; Cushman M; Daviglus M; Demmer RT; Elkind MSV; Gallo LC; Gutierrez JD; Howard VJ; Isasi CR; Judd SE; Kanaya AM; Kandula NR; Kaplan RC; Kinney GL; Kucharska-Newton AM; Lackland DT; Lee JS; Make BJ; Min YI; Murabito JM; Norwood AF; Ortega VE; Pettee Gabriel K; Psaty BM; Regan EA; Sotres-Alvarez D; Schwartz D; Shikany JM; Thyagarajan B; Tracy RP; Umans JG; Vasan RS; Wenzel SE; Woodruff PG; Xanthakis V; Zhang Y; Post WS
JAMA Netw Open; 2024 Jun; 7(6):e2417440. PubMed ID: 38884994
[TBL] [Abstract][Full Text] [Related]
27. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
Rodríguez-Grande C; Estévez A; Palomino-Cabrera R; Molero-Salinas A; Peñas-Utrilla D; Herranz M; Sanz-Pérez A; Alcalá L; Veintimilla C; Catalán P; Martínez-Laperche C; Alonso R; Muñoz P; Pérez-Lago L; de Viedma DG;
Emerg Infect Dis; 2023 Jun; 29(6):1154-1161. PubMed ID: 37130503
[TBL] [Abstract][Full Text] [Related]
28. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.
Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R
Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285
[TBL] [Abstract][Full Text] [Related]
29. Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.
Flacco ME; Soldato G; Acuti Martellucci C; Di Martino G; Carota R; Caponetti A; Manzoli L
Front Public Health; 2022; 10():884121. PubMed ID: 35586006
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 reinfections during the Delta and Omicron waves.
Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
[TBL] [Abstract][Full Text] [Related]
31. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
[TBL] [Abstract][Full Text] [Related]
32. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
[TBL] [Abstract][Full Text] [Related]
33. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
Flacco ME; Acuti Martellucci C; Baccolini V; De Vito C; Renzi E; Villari P; Manzoli L
Eur J Clin Invest; 2022 Oct; 52(10):e13845. PubMed ID: 35904405
[TBL] [Abstract][Full Text] [Related]
34. Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
Stich M; Benning L; Speer C; Garbade SF; Bartenschlager M; Kim H; Jeltsch K; Tabatabai J; Niesert M; Janda A; Renk H; Elling R; Hoffmann GF; Kräusslich HG; Müller B; Bartenschlager R; Tönshoff B
J Med Virol; 2023 Mar; 95(3):e28582. PubMed ID: 36794653
[TBL] [Abstract][Full Text] [Related]
35. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
37. Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
Ruff J; Zhang Y; Kappel M; Rathi S; Watkins K; Zhang L; Lockett C
Emerg Infect Dis; 2022 Oct; 28(10):1977-1981. PubMed ID: 35969420
[TBL] [Abstract][Full Text] [Related]
38. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
39. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
[TBL] [Abstract][Full Text] [Related]
40. Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Cohen D; Izak M; Stoyanov E; Mandelboim M; Perlman S; Amir Y; Goren S; Bialik A; Kliker L; Atari N; Yshai R; Zaide Y; Marcus H; Madar-Balakirski N; Israely T; Paran N; Zimhony O; Shinar E; Maor Y; Muhsen K
Int J Infect Dis; 2023 Jul; 132():72-79. PubMed ID: 37072052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
